MedDataX Logo

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients

NCT ID: NCT00543894

Last Updated: 2008-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A prospective, observational, multicenter study (ANTHICUS).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43

NCT01563263

Pseudomonas Aeruginosa Infection
COMPLETED PHASE2/PHASE3

A Cohort Study on Anti-microbial Stewardship in PICU

NCT05862688

Infections
NOT_YET_RECRUITING

Effect of Antibiotic Rotation in the ICU on the Prevalence of Antibiotic Resistant Gram-negative Colonisation

NCT01293071

Infections
COMPLETED PHASE4

Bloodstram Infections in ICU. Single Centre Observational Study.

NCT04926935

Bloodstream Infection Antibiotic Resistant Strain Intensive Care Unit
COMPLETED

Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients

NCT07052604

Pneumonia, Ventilator-Associated Stenotrophomonas Maltophilia Intensive Care Units +2 more
RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infection in ICU

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with hospital-acquired infections and hospitalised in the ICU at one moment of their hospital stay
* Hospital-acquired infections accounting for eligibility are:

* nosocomial pneumonia (including ventilator-associated pneumonia)
* bacteremia
* intra-abdominal infections
* urosepsis
Eligible Sex

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pr Vogelaers

Role: PRINCIPAL_INVESTIGATOR

UZ Gents

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SRP-HB-MER-2005/1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Empiric Antibiotic Therapy for Ventilator-acquired Pneumonia With Gram-negative Bacilli in Intensive Care
NCT02127528 UNKNOWN
Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICU
NCT02413242 COMPLETED
Pilot Study of the Utility of Empiric Antibiotic Therapy for Suspected ICU-Acquired Infection
NCT00438269 COMPLETED PHASE2
Nurse-led Antimicrobial Stewardship Intervention to Increase Antibiotic Appropriateness in Residential Aged Care Facilities
NCT03941509 UNKNOWN NA
COVID-19 and ICU-acquired MDR Bacteria
NCT04378842 COMPLETED
Anaerobic Antibiotic Usage for Pneumonia in the Medical Intensive Care Unit
NCT03046082 COMPLETED
Antimicrobial Therapeutic Drug Monitoring During Lung Transplant Perioperative Phase
NCT06583642 NOT_YET_RECRUITING
DetermInants of Antimicrobial Use aNd De-escalAtion in Critical Care
NCT03664245 UNKNOWN
NOSOcomial COVID-19 in ICU (NOSOCOVID)
NCT04659356 UNKNOWN
Prospective Randomized Controlled Multicenter Trial of 4 Antiseptic Strategies for Prevention of Catheter Infection in Intensive Care Unit for Adults Patients
NCT01629550 COMPLETED PHASE4
Antibiograms of Intensive Care Units at an Egyptian Tertiary Care Hospital
NCT04318613 COMPLETED
Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit
NCT01878643 COMPLETED EARLY_PHASE1
Impact of Antibiotic Treatment on Outcome in Patients With Ventilator-Associated Tracheobronchitis
NCT00122057 COMPLETED NA
Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections
NCT04359693 COMPLETED
Impact of Antibio Prophylaxis on Occurence of Ventilator Associated Pneumonia in Trauma Patients
NCT07059039 COMPLETED
Antifungal Prophylaxis in Intensive Care Unit (ICU) Patients
NCT01495039 COMPLETED PHASE4
Staging Candidiasis in ICU Patients
NCT01322698 COMPLETED
Pseudomonas Aeruginosa Infections Among COVID-19 Patients in Intensive Care Units at CHRU of Nancy (Pyo-COVID-3)
NCT06141837 COMPLETED
Using Antibiotics Wisely - An Antimicrobial Stewardship Program
NCT04388293 UNKNOWN
Early Antibiotics After Aspiration in ICU Patients
NCT05079620 TERMINATED PHASE4
Defining Antibiotic Treatment Duration for Ventilator - Associated Lung Infection
NCT03382548 COMPLETED PHASE3
Antibiotic Therapy Practices for Ventilator-Associated Pneumonia (PETUNIA)
NCT06243094 RECRUITING
Bacterial Transmission Dynamics Study
NCT02401204 COMPLETED
Investigation on the Dynamic Changes in Air Microbiome in Intensive Care Unit
NCT04954300 COMPLETED
Study of Bathing With Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care Unit
NCT00549393 COMPLETED PHASE2/PHASE3